Literature DB >> 12811770

Ethical review of research involving human subjects: when and why is IRB review necessary?

Richard M Wagner1.   

Abstract

Requirements for ethical review of research involving human subjects are based on widely accepted international standards that are implemented by various national regulations and institutional policies. In the United States, most human research is reviewed by institutional review boards (IRBs) applying federal standards. Researchers may not realize the variety of studies that should be submitted for review. Studies involving interventions must be reviewed regardless of whether these are standard interventions, nonmedical interventions, or retrospective studies. Quality improvement activities require IRB review if the results may be published. Research use of information from medical records or of biomedical specimens requires review unless no identifiers are recorded. Review must be sought at least annually and whenever the research changes. Even human research that is technically exempt from Federal regulations usually needs to have that exemption certified by someone other than the researcher. Copyright 2003 Wiley Periodicals, Inc.

Entities:  

Keywords:  Biomedical and Behavioral Research

Mesh:

Year:  2003        PMID: 12811770     DOI: 10.1002/mus.10398

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  3 in total

1.  Canada's new ethical guidelines for research with humans: a critique and comparison with the United States.

Authors:  Joseph Millum
Journal:  CMAJ       Date:  2012-01-16       Impact factor: 8.262

2.  Methodological and ethical quality of randomized controlled clinical trials in gastrointestinal surgery.

Authors:  Valérie Bridoux; Grégoire Moutel; Horace Roman; Babak Kianifard; Francis Michot; Christian Herve; Jean-Jacques Tuech
Journal:  J Gastrointest Surg       Date:  2012-07-10       Impact factor: 3.452

3.  Streamlining ethical review.

Authors:  Joseph Millum; Jerry Menikoff
Journal:  Ann Intern Med       Date:  2010-11-16       Impact factor: 25.391

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.